Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06054165
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2023-03-21
Brief Title:
Impact of a Clinical Pathway for Pelvic Fragility Fractures
Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA
Organization:
Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA
Study Overview
Official Title:
Impact of Regional Implementation of a Clinical Pathway for ELderly Patients With pelVIc Fragility fraCtures PELVIC a Multicenter Stepped-wedge Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PELVIC
Brief Summary:
Patients with pelvic fragility fractures suffer from high morbidity and mortality rates Despite the high incidence of these injuries there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice New insights in treatment strategies such as early diagnosis and minimal invasive operative treatment of these fragile patient population has led to the development of several clinical pathways in recent literature The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None